Newsroom | 2769 results

PARSIPPANY, N.J.--(BUSINESS WIRE)--Zoetis Inc. today announced that Health Canada has approved Portela™ (relfovetmab injection) for the alleviation of pain associated with osteoarthritis (OA) in cats. Designed to provide three months of OA pain relief with a single injection, Portela targets anti-nerve growth factor (NGF), which is a key mediator of OA pain and inflammation. In a nine-month field trial in Europe, Portela demonstrated effectiveness in alleviating OA pain and was found to be well...

BRISBANE, Australia--(BUSINESS WIRE)--Dial A Vet, Australia’s fastest-growing veterinary telehealth platform, has announced a national partnership with Pawssum Mobile Vets, Australia’s largest Mobile vet service, to launch the country’s first fully integrated online-to-in-home veterinary care pathway. This collaboration bridges the gap between digital advice and physical treatment, offering Australian pet owners a seamless veterinary experience. Through this alliance, owners receive immediate o...

RAHWAY, N.J.--(BUSINESS WIRE)--Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the U.S. Food and Drug Administration (FDA) has granted a conditional approval for EXZOLT™ CATTLE-CA1 (fluralaner topical solution). This innovative product is in the newest class of parasiticides known as isoxazolines. The pour-on solution is effective for the prevention and treatment of infest...

HENDERSON, Nev.--(BUSINESS WIRE)--Roseman University has appointed Christina V. Tran, DVM, as executive associate dean of the university’s proposed College of Veterinary Medicine....

AUSTIN, Texas--(BUSINESS WIRE)--Otto, the veterinary technology company trusted by more than 5,000 clinics, today announced that Hill’s Pet Nutrition and The Veterinary Cooperative (TVC) are partnering with Otto to provide clinics with access free of charge to Otto AI Scribe, expanding the availability of veterinary-specific documentation tools to Hill’s Connect clinic partners and to TVC member clinics. This collaboration marks a major step forward in giving veterinary teams access to the indu...

NEW YORK--(BUSINESS WIRE)--Small Door Veterinary, the membership-based veterinary care company reimagining the pet health experience, today announced that it has hired Mikhayl Alam as its new Chief Financial Officer and Collin Russell as Head of People. The additions come on the heels of a record year of profitability and a $55 million capital raise, positioning the company to accelerate expansion with six new locations slated to open next year. Alam brings over 15 years of experience driving g...

MILL VALLEY, Calif.--(BUSINESS WIRE)--FCPT Announces Acquisition of a VCA Animal Hospital Property for $5.8 Million...

PARSIPPANY, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE: ZTS), the world’s leading animal health company, will host an Innovation Webcast today at 8:30 a.m. ET to provide an update on its proven innovation model, robust and diversified R&D pipeline, and upcoming growth catalysts as the company continues pioneering the future of animal health. “The pace of animal health innovation is accelerating alongside a growing appreciation for the essential role animals play in our lives and communities....

TORONTO--(BUSINESS WIRE)--Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (OTC: MVMDF) (FRA: 20MP) is pleased to provide an update on recent Agrarius™ agricultural product trial results, including key outcomes from its ongoing citrus field trials in Brazil and cattle pasture grass trials in Colombia. These trial programs are intended to support the Company’s customer product adoption strategy and commercial development initiatives for its licensed Agrarius agricultural pl...

PARSIPPANY, N.J.--(BUSINESS WIRE)--Zoetis Inc. today announced that the European Commission has granted the company marketing authorization for Lenivia® (izenivetmab) for the reduction of pain associated with osteoarthritis (OA) in dogs. Lenivia is a new antibody therapy that reduces OA pain in dogs for three months with one injection through its novel binding properties to nerve growth factor (NGF), recognized as an important mediator of pain and inflammation. Lenivia is built on a decade of s...